About-cancer/treatment/drugs/ovarian

Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for ovarian, fallopian tube, or primary peritoneal cancer. The list includes generic and brand names. This page also lists common drug combinations used in these cancer types. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.

The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in ovarian, fallopian tube, or primary peritoneal cancer that are not listed here.

Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Alkeran (Melphalan)

Avastin (Bevacizumab)

Bevacizumab

Carboplatin

Cisplatin

Cyclophosphamide

Doxorubicin Hydrochloride

Doxil (Doxorubicin Hydrochloride Liposome)

Doxorubicin Hydrochloride Liposome

Gemcitabine Hydrochloride

Gemzar (Gemcitabine Hydrochloride)

Hycamtin (Topotecan Hydrochloride)

Lynparza (Olaparib)

Melphalan

Niraparib Tosylate Monohydrate

Olaparib

Paclitaxel

Rubraca (Rucaparib Camsylate)

Rucaparib Camsylate

Taxol (Paclitaxel)

Thiotepa

Topotecan Hydrochloride

Zejula (Niraparib Tosylate Monohydrate)

Drug Combinations Used in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

BEP

CARBOPLATIN-TAXOL

GEMCITABINE-CISPLATIN

JEB

PEB

VAC

VeIP